Winfield Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-300
Closed -$20K 835
2017
Q3
$20K Hold
300
0.01% 290
2017
Q2
$23K Hold
300
0.01% 266
2017
Q1
$24K Hold
300
0.01% 245
2016
Q4
$22K Hold
300
0.01% 250
2016
Q3
$23K Sell
300
-56
-16% -$4.53K 0.01% 237
2016
Q2
$27K Buy
356
+56
+19% +$4.46K 0.02% 224
2016
Q1
$25K Hold
300
0.02% 217
2015
Q4
$27K Hold
300
0.02% 197
2015
Q3
$23K Hold
300
0.02% 198
2015
Q2
$25K Hold
300
0.02% 189
2015
Q1
$27K Hold
300
0.02% 190
2014
Q4
$24K Hold
300
0.02% 194
2014
Q3
$22K Hold
300
0.02% 195
2014
Q2
$20K Buy
+300
New +$20.4K 0.01% 215

Other funds holding CAH

Winfield Associates's CAH Position: Q4 2017 in Review

Winfield Associates sold out of Cardinal Health (CAH) in Q4 2017, closing a stake of 300 shares — an estimated $20K sold.

Winfield Associates first reported a position in CAH in Q2 2014 and held it in 14 quarters. The position peaked at $27K in Q2 2016. 722 funds tracked by Wall St. Rank hold CAH as of Q4 2017.

  • Winfield Associates reported no remaining Cardinal Health position as of Q4 2017 after selling out during the quarter.
  • Winfield Associates sold 300 Cardinal Health shares in Q4 2017, an estimated $20K.
  • Winfield Associates first reported a position in Cardinal Health in Q2 2014 and held it in 14 quarters.
  • Winfield Associates's Cardinal Health position peaked at $27K in Q2 2016.
  • 722 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2017.

Based on Winfield Associates's 13F filing for Q4 2017, filed 12 Feb 2018.